Jeuveau

Jeuveau is the newest neurotoxin to come to the cosmetic injection line. It was released in May 2019. Jeuveau comes from the French word “nouveau” that translates modern or up-to-date. It is the first neurotoxin that has been FDA approved for cosmetic purposes only. Most of the other neurotoxins have FDA approval for medical purposes as well as cosmetic purposes. The company has launched with hopes of attracting patients through social media. #NEWTOX can be searched on social media sites for results and information on the neurotoxin.

In studies, Jeuveau has reported that patients retreat on average 3 times per year. We have begun our own in office comparison of the neurotoxins for duration and effect. The effects seem to be very similar to Botox thus far. As far as duration, we are still monitoring this aspect of the product. Stay tuned for updates on duration!

Questions?

Reach out to our office at 216.514.8899 or info@drgoldman.com